(S1 (S (S (NP (NP (JJ Endothelial) (NN cell) (NN migration)) (CC and) (NP (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor)) (NN expression))) (VP (VBP are) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (NP (NN loss)) (PP (IN of) (NP (NN breast) (NN tissue) (CD polarity)))))))) (. .)))
(S1 (S (S (S (VP (VBG Recruiting) (NP (DT a) (JJ new) (NN blood) (NN supply)))) (VP (VBZ is) (NP (NP (DT a) (JJ rate-limiting) (NN step)) (PP (IN in) (NP (NN tumor) (NN progression)))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NP (DT a) (JJ three-dimensional) (NN model)) (PP (IN of) (NP (NN breast) (NN carcinogenesis))))) (, ,) (NP (ADJP (ADJP (JJ disorganized)) (, ,) (ADJP (JJ proliferative))) (VBN transformed) (NN breast) (NN epithelial) (NNS cells)) (VP (VBP express) (NP (NP (ADJP (RB significantly) (JJR higher)) (NN expression)) (PP (IN of) (NP (JJ angiogenic) (NNS genes)))) (PP (VBN compared) (PP (IN with) (NP (PRP$ their) (ADJP (ADJP (VBN polarized)) (, ,) (ADJP (JJ growth-arrested))) (JJ nonmalignant) (NNS counterparts)))))) (. .)))
(S1 (S (S (NP (NP (JJ Elevated) (NP (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN VEGF)) (-RRB- -RRB-))) (NN secretion)) (PP (IN by) (NP (JJ malignant) (NNS cells)))) (VP (VBD enhanced) (NP (NP (NN recruitment)) (PP (IN of) (NP (NP (JJ endothelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN EC)) (-RRB- -RRB-))))) (PP (IN in) (NP (JJ heterotypic) (NNS cocultures))))) (. .)))
(S1 (S (S (ADVP (RB Significantly)) (, ,) (NP (NP (JJ phenotypic) (NN reversion)) (PP (IN of) (NP (JJ malignant) (NNS cells))) (PP (IN via) (NP (NP (NN reexpression)) (PP (IN of) (NP (NN HoxD10))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN lost) (PP (IN in) (NP (JJ malignant) (NN progression))))))) (, ,)) (ADVP (RB significantly)) (VP (VP (VBD attenuated) (NP (NP (NN VEGF) (NN expression)) (PP (IN in) (NP (NP (DT a) (JJ hypoxia-inducible) (NN factor)) (JJ 1alpha-independent) (NN fashion))))) (CC and) (VP (VBD reduced) (NP (NN EC) (NN migration))))) (. .)))
(S1 (S (S (NP (DT This)) (VP (VBD was) (PP (JJ due) (ADVP (RB primarily)) (TO to) (S (VP (VBG restoring) (NP (NN polarity))))))) (: :) (S (NP (NP (VBN forced) (NN proliferation)) (PP (IN of) (NP (VBN polarized) (, ,) (NP (JJ nonmalignant) (NNS cells))))) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (NN VEGF) (NN expression)) (CC and) (NP (NN EC) (NN recruitment)))) (, ,) (SBAR (IN whereas) (S (VP (VBG disrupting) (NP (NP (DT the) (NN architecture)) (PP (IN of) (NP (JJ growth-arrested))))))))) (, ,) (S (NP (VBD reverted) (NNS cells)) (VP (VBD did))) (. .)))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (S (VP (VP (VBG disrupting) (S (NP (NN cytostructure)) (VP (VBZ activates) (NP (DT the) (JJ angiogenic) (NN switch)) (PP (ADVP (RB even)) (IN in) (DT the) (NN absence) (IN of) (NP (NP (NN proliferation)) (CC and/or) (NP (NN hypoxia))))))) (CC and) (VP (VBG restoring) (NP (NP (NN organization)) (PP (IN of) (NP (JJ malignant) (NNS clusters))))))) (VP (VBZ reduces) (NP (NP (NN VEGF) (NN expression)) (CC and) (NP (NN EC) (NN activation))) (PP (TO to) (NP (NP (NNS levels)) (VP (VBN found) (PP (IN in) (NP (JJ quiescent) (JJ nonmalignant) (NN epithelium))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP confirm) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (NN tissue) (NN architecture)) (CC and) (NP (NN polarity)))) (PP (IN in) (NP (JJ malignant) (NN progression)))))) (. .)))
